Lyra Therapeutics Statistics
Total Valuation
LYRA has a market cap or net worth of 940,687. The enterprise value is 15.31 million.
| Market Cap | 940,687 |
| Enterprise Value | 15.31M |
Important Dates
The next estimated earnings date is Wednesday, April 29, 2026.
| Earnings Date | Apr 29, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
LYRA has 1.77 million shares outstanding. The number of shares has increased by 19.29% in one year.
| Current Share Class | 1.77M |
| Shares Outstanding | 1.77M |
| Shares Change (YoY) | +19.29% |
| Shares Change (QoQ) | +0.54% |
| Owned by Insiders (%) | 61.20% |
| Owned by Institutions (%) | 6.15% |
| Float | 395,689 |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 2.36 |
| PB Ratio | -0.09 |
| P/TBV Ratio | n/a |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | -0.53 |
| EV / Sales | 38.46 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | -0.53 |
Financial Position
The company has a current ratio of 1.71
| Current Ratio | 1.71 |
| Quick Ratio | 1.67 |
| Debt / Equity | n/a |
| Debt / EBITDA | n/a |
| Debt / FCF | -1.04 |
| Interest Coverage | n/a |
Financial Efficiency
Return on equity (ROE) is -6,594.98% and return on invested capital (ROIC) is -56.39%.
| Return on Equity (ROE) | -6,594.98% |
| Return on Assets (ROA) | -36.06% |
| Return on Invested Capital (ROIC) | -56.39% |
| Return on Capital Employed (ROCE) | -111.16% |
| Weighted Average Cost of Capital (WACC) | 0.18% |
| Revenue Per Employee | 13,267 |
| Profits Per Employee | -963,967 |
| Employee Count | 30 |
| Asset Turnover | 0.01 |
| Inventory Turnover | n/a |
Taxes
In the past 12 months, LYRA has paid 11,000 in taxes.
| Income Tax | 11,000 |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -91.21% in the last 52 weeks. The beta is 0.30, so LYRA's price volatility has been lower than the market average.
| Beta (5Y) | 0.30 |
| 52-Week Price Change | -91.21% |
| 50-Day Moving Average | 1.17 |
| 200-Day Moving Average | 4.82 |
| Relative Strength Index (RSI) | 31.12 |
| Average Volume (20 Days) | 92,265 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | 0.42 |
Income Statement
In the last 12 months, LYRA had revenue of 398,000 and -28.92 million in losses. Loss per share was -18.62.
| Revenue | 398,000 |
| Gross Profit | -608,000 |
| Operating Income | -29.55M |
| Pretax Income | -28.91M |
| Net Income | -28.92M |
| EBITDA | -29.09M |
| EBIT | -29.55M |
| Loss Per Share | -18.62 |
Balance Sheet
The company has 15.89 million in cash and 30.26 million in debt, with a net cash position of -14.37 million or -8.09 per share.
| Cash & Cash Equivalents | 15.89M |
| Total Debt | 30.26M |
| Net Cash | -14.37M |
| Net Cash Per Share | -8.09 |
| Equity (Book Value) | -10.72M |
| Book Value Per Share | -6.04 |
| Working Capital | 6.75M |
Cash Flow
In the last 12 months, operating cash flow was -28.86 million and capital expenditures -116,000, giving a free cash flow of -28.98 million.
| Operating Cash Flow | -28.86M |
| Capital Expenditures | -116,000 |
| Depreciation & Amortization | 459,000 |
| Net Borrowing | n/a |
| Free Cash Flow | -28.98M |
| FCF Per Share | -16.33 |
Margins
| Gross Margin | -152.76% |
| Operating Margin | -7,425.38% |
| Pretax Margin | -7,263.32% |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |
Dividends & Yields
LYRA does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -19.29% |
| Shareholder Yield | -19.29% |
| Earnings Yield | -3,074.24% |
| FCF Yield | -3,080.20% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
The last stock split was on May 28, 2025. It was a reverse split with a ratio of 0.02.
| Last Split Date | May 28, 2025 |
| Split Type | Reverse |
| Split Ratio | 0.02 |
Scores
LYRA has an Altman Z-Score of -19.14 and a Piotroski F-Score of 1. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | -19.14 |
| Piotroski F-Score | 1 |